Stimcell Energetics (STME) Free Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.66% |
| Nov 30, 2025 | 12.45% |
| Aug 31, 2025 | 8.78% |
| May 31, 2025 | 24.00% |
| Feb 28, 2025 | 27.35% |
| Nov 30, 2024 | 43.05% |
| Aug 31, 2024 | 35.55% |
| May 31, 2024 | 20.57% |
| Feb 29, 2024 | 23.21% |
| Nov 30, 2023 | -13.49% |
| Aug 31, 2023 | 2.83% |
| May 31, 2023 | 3.59% |
| Feb 28, 2023 | -3.88% |
| Nov 30, 2022 | 21.38% |
| Aug 31, 2022 | 6.93% |
| May 31, 2022 | 13.38% |
| Feb 28, 2022 | 19.03% |
| Nov 30, 2021 | 16.03% |
| Aug 31, 2021 | -1.83% |
| May 31, 2021 | 11.28% |
| May 31, 2018 | -80.63% |
| Feb 28, 2018 | -68.29% |
| Nov 30, 2017 | -116.71% |
| May 31, 2017 | -92.13% |
| Nov 30, 2016 | -96.92% |
| Aug 31, 2016 | -125.23% |
| May 31, 2016 | -83.68% |